Tyler Scarborough, an 8-year-old boy with congenital heart disease, is the focus of a local military family's efforts to ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Nitric Boost Ultra is a male health supplement that has gained popularity due to its unique and research-backed working ...

The supplement industry is booming—but so are serious health issues tied to taking these pills and powders. Here’s what ...

Weill Cornell Medicine researchers have found that intracranial hemorrhages, or "brain bleeds," caused by a ruptured blood ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

A fatal explosion at a Michigan clinic has raised concerns about the growing use of hyperbaric oxygen therapy.

Managing cravings and maintaining a healthy diet can feel overwhelming in today’s fast-paced world. With countless products ...

A study of patients Dallas paramedics treated in 2023 found as many as 674 could have benefited from blood transfusions en ...

Ed Hinton’s journalism is one of the main reasons a NASCAR driver hasn’t died on the track since Dale Earnhardt in 2001 ...

The teenagers perished when the vehicle collided with a tree and erupted in flames, causing Dixon and passengers Krysta ...

Agios' mitapivat met its primary endpoint in a Phase 3 trial for PK deficiency in children. The company plans a marketing application based on the results.